Abbvie (ABBV) PT Raised to $260 at Freedom Capital Markets
Tweet
Share
E-mailGet Alerts ABBV Hot Sheet
Price: $249.46 --0%
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 19
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 19
Join SI Premium – FREE
Freedom Capital Markets analyst Ilya Zubkov raised the price target on Abbvie (NYSE: ABBV) to $260.00 (from $245.00) while maintaining a Buy rating.
You May Also Be Interested In
- Wolfe Research Upgrades Abbvie (ABBV) to Outperform
- The Elmet Group (ELMT) PT Raised to $21 at Canaccord
- Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
